Skip to main content

Table 2 HSDS and ΔHSDS by diagnostic category.

From: Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®

  HSDS ΔHSDS
  n Mean (SD) n Mean (SD)
GHD     
   Baseline 698 -2.22 (0.86) - -
   4 Months 698 -2.03 (0.82) 698 0.19 (0.33)
   Year 1 698 -1.61 (0.83) 698 0.61 (0.49)
   Year 2 697 -1.17 (0.88) 697 1.06 (0.64)
MPHD     
   Baseline 71 -1.98 (1.36) - -
   4 Months 70 -1.62 (1.30) 70 0.37 (0.68)
   Year 1 70 -1.13 (1.04) 70 0.85 (0.76)
   Year 2 70 -0.79 (1.04) 70 1.20 (1.04)
Turner     
   Baseline 60 -2.49 (0.77) - -
   4 Months 59 -2.32 (0.82) 59 0.18 (0.20)
   Year 1 60 -1.99 (0.86) 60 0.50 (0.31)
   Year 2 60 -1.68 (0.90) 60 0.82 (0.43)
SGA     
   Baseline 50 -2.76 (0.97) - -
   4 Months 50 -2.48 (0.88) 50 0.28 (0.47)
   Year 1 50 -1.96 (0.93) 50 0.80 (0.59)
   Year 2 50 -1.59 (1.00) 50 1.18 (0.65)
ISS     
   Baseline 123 -2.31 (0.68) - -
   4 Months 123 -2.16 (0.69) 123 0.15 (0.19)
   Year 1 123 -1.77 (0.69) 123 0.54 (0.38)
   Year 2 123 -1.41 (0.79) 123 0.90 (0.59)
  1. GHD, growth hormone deficiency; HSDS, height standard deviation score; ISS, idiopathic short stature; MPHD, multiple pituitary hormone deficiency; SD, standard deviation; SGA, small for gestational age.